GREENLIGHT BIOSCIENCES HOLDINGS

Inactive Instrument

Highlights GreenLight Biosciences Holdings

Equities

GRNA

US39536G1058

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

A group of buyers led by Fall Line Endurance Fund, Lp, managed by Fall Line Capital, LLC completed the acquisition of GreenLight Biosciences Holdings from stockholders.	23/07/23	CI
GreenLight Biosciences Holdings Reports Earnings Results for the First Quarter Ended March 31, 2023	11/05/23	CI
An affiliate of Fall Line Endurance Fund, Lp, managed by Fall Line Capital, LLC agreed to acquire GreenLight Biosciences Holdings from stockholders for $42.1 million.	29/03/23	CI
Rwanda FDA approves Platform Life Sciences and GreenLight Biosciences to launch a Phase I clinical trial in Rwanda for mRNA COVID-19 vaccine	02/02/23	CI
Greenlight Biosciences Holdings Receives Approval to Initiate Phase I/II Clinical Trial of Covid-19 Mrna Vaccine Candidate	01/02/23	CI
Greenlight Biosciences and Epivax Therapeutics Signs Exclusive Collaboration Agreement to Develop Personalized Cancer Vaccines	09/01/23	CI
GreenLight Biosciences Holdings Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	09/11/22	CI
GreenLight Biosciences and Queensland University of Technology Partner to Tackle Destructive Fall Armyworm Using RNA	05/10/22	CI
GreenLight Biosciences : INDEX TO FINANCIAL STATEMENTS - Form 8-K	26/09/22	PU
GreenLight Biosciences and Samsung Biologics Completes First Commercial-Scale Engineering Run for mRNA Covid-19 Vaccine	01/08/22	CI
National Institutes of Health, GreenLight Biosciences to Collaborate on COVID-19 Vaccine Development for New Variants	29/07/22	CI
Greenlight Biosciences Holdings Announces Licensing Agreement with Serum Institute of India, Pvt, Ltd., Aimed at Accelerating Accessibility to Messenger RNA Products in Emerging Markets Globally	14/03/22	CI
GreenLight Biosciences Holdings Agrees to Field Station in Spain to Boost Research and Development for Key Plant Health Projects	07/02/22	CI
GreenLight Biosciences, Inc. completed the acquisition of Environmental Impact Acquisition Corp. from HB Strategies LLC, CG Investments Inc. VI and others in a reverse merger transaction.	01/02/22	CI
GreenLight Biosciences, Inc. executed a letter of intent to acquire Environmental Impact Acquisition Corp. from HB Strategies LLC, CG Investments Inc. VI and others for $1.2 billion in a reverse merger transaction.	09/08/21	CI
Feasibility Arrangement for Shelf-Stable Powder Form of Messenger RNA Covid-19 Vaccine Candidate Announces by GreenLight Biosciences and TFF Pharmaceuticals	09/03/21	CI
GreenLight Biosciences Announces New Partnership with Bayer CropScience	25/02/14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer